Legend Biotech Corp. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (9)

View All

Latest Posts

About This Stock More About This Stock
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
Article By: Zacks Investment Research
Saturday, March 9, 2024 4:00 PM EDT
Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the year.
In this article: EXEL, EXAS, ASND, LEGN, MOR
Read
Week In Review: AlphaGen And ArtBio Form China-US Radioligand Partnership
Article By: ChinaBio® Today
Saturday, February 24, 2024 2:20 PM EDT
Shanghai AlphaGen Therapeutics and ArtBio forged a far-reaching agreement to expand ArtBio’s market and develop new radioligand therapies. Additionally, Biocytogen Pharma signed an antibody evaluation/option agreement with Gilead Sciences.
In this article: GILD, LEGN, IVBXF, JBPHF, SMHGF
Read
Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
Article By: ChinaBio® Today
Saturday, November 18, 2023 2:00 PM EDT
Legend Biotech partnered its DLL3 CAR-T candidates to Novartis in a $1.2 billion agreement, with $100 million offered upfront. Novartis will own worldwide rights to develop, manufacture, and commercialize the DLL3 group of cell therapies.
In this article: NVS, TBPH, LEGN, VTRS, APLM Also: WXXWY
Read
All Posts

Latest Tweets for $LEGN

No tweets yet!

PARTNER HEADLINES